Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103


Comparison of the anti-inflammatory and therapeutic actions of PPAR-gamma agonists rosiglitazone and troglitazone in experimental colitis.

Celinski K, Dworzanski T, Fornal R, Korolczuk A, Madro A, Slomka M.

J Physiol Pharmacol. 2012 Dec;63(6):631-40.


Effects of peroxisome proliferator-activated receptors-gamma ligands on dextran sodium sulphate-induced colitis in rats.

Celinski K, Dworzanski T, Korolczuk A, Piasecki R, Slomka M, Madro A, Fornal R.

J Physiol Pharmacol. 2011 Jun;62(3):347-56.


The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis.

Ramakers JD, Verstege MI, Thuijls G, Te Velde AA, Mensink RP, Plat J.

J Clin Immunol. 2007 May;27(3):275-83. Epub 2007 Feb 14.


Activated and inactivated PPARs-γ modulate experimentally induced colitis in rats.

Celinski K, Dworzanski T, Korolczuk A, Slomka M, Radej S, Cichoz-Lach H, Madro A.

Med Sci Monit. 2011 Apr;17(4):BR116-24.


The intestinal anti-inflammatory effect of dersalazine sodium is related to a down-regulation in IL-17 production in experimental models of rodent colitis.

Camuesco D, Rodríguez-Cabezas ME, Garrido-Mesa N, Cueto-Sola M, Bailón E, Comalada M, Arribas B, Merlos M, Balsa D, Zarzuelo A, Janer G, Xaus J, Román J, Gálvez J.

Br J Pharmacol. 2012 Feb;165(3):729-40. doi: 10.1111/j.1476-5381.2011.01598.x.


Anti-inflammatory effects of Mangifera indica L. extract in a model of colitis.

Márquez L, Pérez-Nievas BG, Gárate I, García-Bueno B, Madrigal JL, Menchén L, Garrido G, Leza JC.

World J Gastroenterol. 2010 Oct 21;16(39):4922-31.


Perilla frutescens extract ameliorates DSS-induced colitis by suppressing proinflammatory cytokines and inducing anti-inflammatory cytokines.

Urushima H, Nishimura J, Mizushima T, Hayashi N, Maeda K, Ito T.

Am J Physiol Gastrointest Liver Physiol. 2015 Jan 1;308(1):G32-41. doi: 10.1152/ajpgi.00294.2014. Epub 2014 Oct 30.


Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats.

Sánchez-Hidalgo M, Martín AR, Villegas I, Alarcón De La Lastra C.

Biochem Pharmacol. 2005 Jun 15;69(12):1733-44.


Rosiglitazone treatment attenuates renal tissue inflammation generated by urinary tract obstruction.

Efrati S, Berman S, Chachashvili A, Cohen N, Siman-Tov Y, Averbukh Z, Weissgarten J.

Nephrology (Carlton). 2009 Apr;14(2):189-97. doi: 10.1111/j.1440-1797.2008.01032.x.


On the benefit of Teucrium in murine colitis through improvement of toxic inflammatory mediators.

Abdolghaffari AH, Baghaei A, Moayer F, Esmaily H, Baeeri M, Monsef-Esfahani HR, Hajiaghaee R, Abdollahi M.

Hum Exp Toxicol. 2010 Apr;29(4):287-95. doi: 10.1177/0960327110361754. Epub 2010 Feb 9.


Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.

Koufany M, Moulin D, Bianchi A, Muresan M, Sebillaud S, Netter P, Weryha G, Jouzeau JY.

Arthritis Res Ther. 2008;10(1):R6. doi: 10.1186/ar2354. Epub 2008 Jan 16.


Expression of peroxisome proliferator-activated receptor-gamma in macrophage suppresses experimentally induced colitis.

Shah YM, Morimura K, Gonzalez FJ.

Am J Physiol Gastrointest Liver Physiol. 2007 Feb;292(2):G657-66. Epub 2006 Nov 9.


Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.

Sánchez-Hidalgo M, Martín AR, Villegas I, de la Lastra CA.

Eur J Pharmacol. 2007 May 21;562(3):247-58. Epub 2007 Feb 1.


Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis.

Saubermann LJ, Nakajima A, Wada K, Zhao S, Terauchi Y, Kadowaki T, Aburatani H, Matsuhashi N, Nagai R, Blumberg RS.

Inflamm Bowel Dis. 2002 Sep;8(5):330-9.


Faecalibacterium prausnitzii supernatant ameliorates dextran sulfate sodium induced colitis by regulating Th17 cell differentiation.

Huang XL, Zhang X, Fei XY, Chen ZG, Hao YP, Zhang S, Zhang MM, Yu YQ, Yu CG.

World J Gastroenterol. 2016 Jun 14;22(22):5201-10. doi: 10.3748/wjg.v22.i22.5201.


Chymase inhibitor TY-51469 in therapy of inflammatory bowel disease.

Liu WX, Wang Y, Sang LX, Zhang S, Wang T, Zhou F, Gu SZ.

World J Gastroenterol. 2016 Feb 7;22(5):1826-33. doi: 10.3748/wjg.v22.i5.1826.

Supplemental Content

Support Center